Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Recs

0
Player Avatar 2trpop (30.91) Submitted: 1/17/2012 9:17:40 AM : Outperform Start Price: $77.77 REGN Score: +37.49

momentum Play

Featured Broker Partners


Advertisement